Pfizer submits Phase 1 results of COVID-19 vaccine booster trial to FDA for review
Pfizer on Monday announced it submitted data to the Food and Drug Administration regarding the results of Phase 1 trials for a potential COVID-19 vaccine booster shot.In a press re…